BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gonzalez JV, Barboza AG, Vazquez FJ, Gándara E. Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0151607. [PMID: 27031503 DOI: 10.1371/journal.pone.0151607] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Cui L, Li Y, Zhu L, Wang C, Liu J, Fang S. Prevalence and geographical variation of Factor V Leiden in patients with cerebral venous thrombosis: A meta-analysis. PLoS One 2018;13:e0203309. [PMID: 30157246 DOI: 10.1371/journal.pone.0203309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Islam MA, Khandker SS, Alam F, Kamal MA, Gan SH. Genetic risk factors in thrombotic primary antiphospholipid syndrome: A systematic review with bioinformatic analyses. Autoimmun Rev 2018;17:226-43. [PMID: 29355608 DOI: 10.1016/j.autrev.2017.10.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
3 Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Collantes E, Aguirre MA, Perez-Sanchez C. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches. Front Immunol 2019;10:764. [PMID: 31040845 DOI: 10.3389/fimmu.2019.00764] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
4 Gürtler L, Seitz R, Schramm W. Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine? Infection 2021. [PMID: 34286453 DOI: 10.1007/s15010-021-01658-x] [Reference Citation Analysis]
5 Ferro JM, Canhão P, Aguiar de Sousa D. Cerebral venous thrombosis. La Presse Médicale 2016;45:e429-50. [DOI: 10.1016/j.lpm.2016.10.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
6 Ahmed SA, Hameed SA, Hussen BM, Salihi A. Prevalence of the prothrombin G20210A mutation among ischemic stroke patients. J Cardiovasc Thorac Res 2020;12:227-30. [PMID: 33123330 DOI: 10.34172/jcvtr.2020.39] [Reference Citation Analysis]
7 Ken-Dror G, Cotlarciuc I, Martinelli I, Grandone E, Hiltunen S, Lindgren E, Margaglione M, Duchez VLC, Triquenot AB, Zedde M, Mancuso M, Ruigrok YM, Marjot T, Worrall B, Majersik JJ, Metso TM, Putaala J, Haapaniemi E, Zuurbier SM, Brouwer MC, Passamonti SM, Abbattista M, Bucciarelli P, Mitchell BD, Kittner SJ, Lemmens R, Jern C, Pappalardo E, Costa P, Colombi M, de Sousa DA, Rodrigues S, Canhão P, Tkach A, Santacroce R, Favuzzi G, Arauz A, Colaizzo D, Spengos K, Hodge A, Ditta R, Pezzini A, Debette S, Coutinho JM, Thijs V, Jood K, Pare G, Tatlisumak T, Ferro JM, Sharma P. Genome-Wide Association Study Identifies First Locus Associated with Susceptibility to Cerebral Venous Thrombosis. Ann Neurol 2021;90:777-88. [PMID: 34459509 DOI: 10.1002/ana.26205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Elkattawy S, Alyacoub R, Singh KS, Fichadiya H, Kessler W. Prothrombin G20210A Gene Mutation-Induced Recurrent Deep Vein Thrombosis and Pulmonary Embolism: Case Report and Literature Review. J Investig Med High Impact Case Rep 2022;10:23247096211058486. [PMID: 35426321 DOI: 10.1177/23247096211058486] [Reference Citation Analysis]
9 Freed J, Bauer KA. Thrombophilia. Consultative Hemostasis and Thrombosis. Elsevier; 2019. pp. 242-65. [DOI: 10.1016/b978-0-323-46202-0.00014-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]